败血症中的肠-肺免疫代谢交叉:从微生物群到呼吸衰竭
Qixiu Li1,2, Xi-Cheng Song3, Kefeng Li4
1The Second Clinical Medical College of Binzhou Medical University, Yantai, China.
Frontiers in medicine
|November 17, 2025
概括
败血症破坏了肠肺轴,通过微生物群变化恶化肺损伤. 干预措施有希望,但需要个性化的方法来有效治疗败血症.
科学领域:
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 败血症是一种系统性免疫代谢障碍,涉及肠道微生物群.
- 肠道失调有助于多器官功能障碍,特别是急性肺损伤 (ALI) 或急性呼吸困扰综合征 (ARDS).
- 肠肺轴描述了肠道微生物群和败血症肺炎之间的双向通信.
研究的目的:
- 系统地阐述肠肺轴在败血症中的双向调节机制.
- 探索像HIF-1α,mTOR和Sirtuins这样的信号通路在败血症期间免疫细胞代谢中的作用.
- 审查目前和未来针对肠肺轴的治疗策略,以治疗与败血症相关的肺损伤.
主要方法:
- 对肠肺轴在败血症中的临床前研究进行系统审查.
- 分析涉及免疫细胞代谢和炎症信号的分子机制.
- 基于微生物群的干预措施和迷走神经刺激的评估.
主要成果:
- 肠道失生症损害了肠道屏障功能,减少了SCFA,并促进了内毒素转移,导致肺炎.
- 肺部炎症加剧了肠道屏障损伤,创造了一个恶性循环.
- 信号通路 (HIF-1α,mTOR,Sirtuins) 动态调节免疫细胞代谢,在超炎症和免疫抑制阶段具有不同的作用.
结论:
- 基于微生物群的干预和迷走神经刺激显示出治疗败血症相关的肺损伤的潜力,但具有个体变异性.
- 未来的研究必须剖析精准医学的信号网络逻辑.
- 开发多omics生物标志物和分层临床试验对于将肠肺轴洞察力转化为个性化败血症治疗至关重要.
相关概念视频
Pneumonia II: Pathophysiology
2.5K
The pathophysiology of pneumonia involves the following steps:
2.5K
Acute Respiratory Failure-V
440
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
440


